Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests

Proceedings of the National Academy of Sciences of the United States of America
T BartfaiJulius Rebek

Abstract

The pharmacological exploitation of the galanin receptors as drug targets for treatment of epilepsy, depression, and pain has been hampered by the lack of workable compounds for medicinal chemists from random screening of large chemical libraries. The present work uses the tripeptidomimetic galnon and displays its presumed pharmacophores on a rigid molecular scaffold. The scaffold is related to marine natural products and presents three functional groups near one another in space, in a manner reminiscent of a protein surface. An active compound, Galmic, was identified from a small synthetic library and tested in vitro and in vivo for its affinity and efficacy at galanin receptors. Galmic has micromolar affinity for GalR1 receptors (Ki = 34.2 microM) and virtually no affinity for GalR2 receptors. In vitro, Galmic, like galanin, suppresses long-term potentiation in the dentate gyrus; it blocks status epilepticus when injected intrahippocampally or administered i.p. Galmic applied i.p. shows antidepressant-like effects in the forced-swim test, and it is a potent inhibitor of flinching behavior in the inflammatory pain model induced by formalin injection. These data further implicate brain and spinal cord galanin receptors as drug ...Continue Reading

References

Oct 14, 1994·European Journal of Pharmacology·E HeuilletJ C Blanchard
Mar 1, 1997·The Journal of Peptide Research : Official Journal of the American Peptide Society·A JuréusT Bartfai
Feb 3, 1999·Annals of the New York Academy of Sciences·T BranchekM W Walker
Feb 26, 2000·Trends in Pharmacological Sciences·T A BranchekM W Walker
May 18, 2001·Journal of Applied Physiology·T L YakshM C Yaksh
Sep 5, 2001·The Journal of Peptide Research : Official Journal of the American Peptide Society·A JaneckaT Janecki
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M KokaiaT Hökfelt
Jan 5, 2002·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·A MazaratiT Bartfai
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Külliki SaarUlo Langel
Dec 19, 2002·Brain Research. Molecular Brain Research·Arie Steven JacobyTiina Pauline Iismaa
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Maria E Vrontakis
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Venetia ZachariouMarina R Picciotto
Jul 25, 2003·Lancet Neurology·Tomas HökfeltFloyd Bloom

❮ Previous
Next ❯

Citations

May 27, 2008·Cellular and Molecular Life Sciences : CMLS·J N Crawley
May 27, 2008·Cellular and Molecular Life Sciences : CMLS·S E CountsE J Mufson
May 17, 2005·Neuroscience and Biobehavioral Reviews·Alasdair M Barr, Athina Markou
Nov 12, 2013·Neuropeptides·Stjepana Kovac, Matthew C Walker
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·H Steve WhiteGrzegorz Bulaj
Mar 20, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul G UnschuldElisabeth B Binder
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaoying LuTamas Bartfai
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daniel Hoyer
Mar 16, 2012·Epilepsia·Jeanelle PortelliIlse Smolders
May 19, 2005·Molecular and Cellular Biology·Michelle L GottschRobert A Steiner
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xiaoying LuTamas Bartfai
Nov 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Susana Conde CeideJulius Rebek
May 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Susanne M BrunnerBarbara Kofler
Jul 30, 2015·Expert Opinion on Therapeutic Targets·Krista FreimannÜlo Langel
Feb 22, 2011·Neurochemistry International·Indrek SaarUlo Langel
Nov 27, 2015·Brain Research·David Weinshenker, Philip V Holmes
Jul 20, 2007·Neuropeptides·S Johannes R RajaraoChad E Beyer
Jan 30, 2007·Pharmacology, Biochemistry, and Behavior·Kathleen R BaileyJacqueline N Crawley
Oct 27, 2005·Journal of Neurochemistry·Stefania PirondiLaura Calzà
Dec 19, 2012·Epilepsia·Pablo M Casillas-EspinosaTerence J O'Brien
Feb 2, 2011·Journal of Neurochemistry·Christopher AbboshWilliam Gray
Mar 3, 2005·Pharmacology, Biochemistry, and Behavior·Rose-Marie KarlssonJacqueline N Crawley
Jun 10, 2005·Neuropeptides·Xiaoying LuTamas Bartfai
Jun 10, 2005·Neuropeptides·Ulla SollenbergUlo Langel
Nov 30, 2004·Neuropeptides·Andrey M Mazarati

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Xiaoying LuT Bartfai
Proceedings of the National Academy of Sciences of the United States of America
Külliki SaarU Langel
© 2022 Meta ULC. All rights reserved